
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Rockson, Cardiologist in Stanford, CA?
Dr. Stanley Rockson, MD is a Cardiologist, who primarily practices in Stanford, CA with 2 additional practice locations. He is board certified. Dr. Rockson graduated from Duke University School of Medicine and completed his residency at Mass Gen Hosp, Cardiovascular Diseases; Brigham & Women'S Hosp, Internal Medicine. Dr. Rockson is fluent in English, French, German, Italian, and Spanish, and is currently seeing new patients. Dr. Rockson’s practice accepts Kaiser Permanente, Medicaid, Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Rockson’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Rockson?
Dr. Stanley Rockson, MD is a highly-rated, board-certified Cardiologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Rockson empowers patients to confidently navigate their health journey, specializing in Peripheral Vascular Disease, Vein Disorders, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Rockson is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Rockson go to medical school and complete their residency?
Fellowship: Massachusetts General Hospital MA
Residency: Mass Gen Hosp, Cardiovascular Diseases; Brigham & Women'S Hosp, Internal Medicine | Brigham and Women's Hospital | Harvard Medical School Affiliated Hospitals | Massachusetts General Hospital Program
Medical School: Duke University School of Medicine | School of Medicine
Is Dr. Rockson board certified as a Cardiologist?
Yes, Dr. Stanley Rockson, MD is board certified by the American Board of Internal Medicine , American Board of Internal Medicine since 1981, American Board of Internal Medicine since 1978
What languages does Dr. Rockson speak?
Dr. Rockson and their clinical team can communicate with patients in the following languages:
English
French
German
Italian
Spanish
What conditions does a Cardiologist like Dr. Rockson typically treat?
As a Cardiologist, Dr. Rockson diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Rockson. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Lymphedema
- Lymphatic Swelling
- Fluid Retention in Limbs
- Chronic Swelling
ICD-10 Codes:
- I890: Lymphedema, not elsewhere classified
Also known as:
- Other Heart Rhythm Disorder
- Arrhythmia
- Cardiac Dysrhythmia
- Irregular Heartbeat
- Heart Rhythm Problems
ICD-10 Codes:
- I498: Other specified cardiac arrhythmias
Also known as:
- Swelling
- Edema
- Fluid Retention
- Bloating
ICD-10 Codes:
- R609: Edema, unspecified
Also known as:
- Chest Pain
- Chest discomfort
- Thoracic pain
- Upper body pain
ICD-10 Codes:
- R079: Chest pain, unspecified
What procedures does a Cardiologist like Dr. Rockson typically perform?
As a Cardiologist, Dr. Rockson performs a variety of medical procedures. This procedure information is derived from anonymized insurance claims and highlights the medical procedures most commonly performed by Dr. Rockson. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Lymph Node X-ray Injection
- Lymphangiography Injection
- Lymphatic System Imaging
- Lymph Vessel Contrast Injection
CPT Codes:
- 38790: Injection procedure; lymphangiography
Does Dr. Rockson accept my insurance?
Dr. Rockson accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Rockson accept in Stanford, CA?
Dr. Rockson in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
All Other Third Party
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
Other Provider Networks
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Rockson's office located?
Recognitions
Awards
David W. Rytand Award for Excellence in Clinical Teaching, Department
Chief Resident s Teaching Award, Stanford University
Dean s Award for Excellence in Teaching, Stanford University
Pioneer Award, Lymphatic Research Foundation
E. William Hancock Cardiovascular Medicine Teaching Award, Stanford U
Franklin G. Ebaugh Jr. Award for Mentoring Medical Students, Stanford
Chief Residents' Teaching Award, Department of Medicine, Stanford Uni
Teaching Award in Cardiology, Department of Medicine, Stanford Univer
Phi Beta Kappa, Duke University
Alpha Omega Alpha, Duke University
John A. White Fellow, North Carolina Arthritis Foundation
Roche Award for Clinical Excellence, Duke University
Samuel Levine Fellow, American Heart Association
David W. Rytand Award for Excellence in Clinical Teaching, Stanford U
Teaching Award in Cardiology, Stanford University
Lymphatic Research Leadership Award, Lymphatic Research Foundation
Publications
The Lymphatics and the Inflammatory Response: Lessons Learned from Human Lymphedema
, 2013
Lymphatics: Where the Circulation Meets the Immune System
, 2013
Assessing extracellular fluid volume in breast cancer lymphedema.
, 2013
Th2 differentiation is necessary for soft tissue fibrosis
, 2013
The Aging Lymphatics Become More Mature
, 2013
Prospective Transcriptomic Pathway Alysis of Human Lymphatic Vascular Insufficiency
, 2012
Experimental lymphedema
, 2012
Lack of Significant Interactions Between Clopidogrel and Proton Pump Inhibitor Therapy
, 2012
Update on the biology and treatment of lymphedema.
, 2012
Cancer Is Part of the Lymphatic Continuum
, 2012
The Lymphatic Biology of Aging
, 2012
Reflections on a Decade of Lymphatic Research and Biology
, 2012
Angiogenesis, Lymphangiogenesis, and Inflammation
, 2012
Temporal and spatial patterns of endogenous danger sigl expression after wound healing and
, 2011
Animal Models for the Mechanistic Study of Systemic Lymphangiomatosis
, 2011
Blockade of Transforming Growth Factor
, 2010
Current concepts and future directions in the diagnosis and magement of lymphatic vascular disease
, 2010
Causes and consequences of lymphatic disease
, 2010
Anti-Inflammatory Pharmacotherapy with Ketoprofen Ameliorates Experimental Lymphatic Vascular
, 2009
Lymphatic research: past, present, and future.
Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema
, 2009
The unique biology of lymphatic edema.
, 2009
Appropriate Secondary Prevention of Acute Atherothrombotic Events
, 2009
The role of the lymphatic circulation in the tural history and expression of cardiovascular disease
, 2008
Diagnosis and magement of lymphatic vascular disease
, 2008
The clinical spectrum of lymphatic disease
, 2008
Gorham's disease - An osseous disease of lymphangiogenesis?
, 2008
Estimating the population burden of lymphedema
, 2008
Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease.
, 2008
Animal models for the molecular and mechanistic study of lymphatic biology and disease
, 2008
The lymphatic continuum revisited - Preface
, 2008
Reinforcing a continuum of care
, 2007
Rapid diagnosis of myocardial injury with troponin T and CK-MB relative index
, 2007
Biomarkers of lymphatic function and disease: state of the art and future directions.
, 2007
Inflammatory manifestations of experimental lymphatic insufficiency
, 2006
Lymphedema.
, 2006
A pilot, prospective evaluation of a novel altertive for maintence therapy of breast cancer
, 2006
Literature watch.
, 2006
Addressing the unmet needs in lymphedema risk magement.
, 2006
The lymphatic continuum continues.
, 2006
Validation of a new technique for the quantitation of edema in the experimental setting.
, 2006
An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis
, 2006
Indirect magnetic resonce lymphangiography to assess lymphatic function
, 2006
Treprostinil for the treatment of severe digital necrosis in systemic sclerosis
, 2005
Therapeutics for lymphatic disease: the role of the pharmaceutical and biotechnology sector.
, 2005
The lymphatic biology of Kaposi's sarcoma.
, 2005
Lymphedema therapy in the vascular anomaly patient: therapeutics for the forgotten circulation.
, 2005
Literature watch. A genetic Xenopus laevis tadpole model to study lymphangiogenesis.
, 2005
Benefits of resident work hours regulation
, 2004
Comparing the guidelines
, 2004
Lymphatic biology and disease: is it being taught? Who is listening?
, 2004
The elusive adipose connection.
, 2004
Tumors, wounds, and lymph.
, 2004
How can lymphatic research influence lymphatic education?
, 2004
The potential for molecular treatment strategies in lymphatic disease.
, 2004
Corory restenosis: A review of mechanisms and magement
, 2003
Endothelial cell diversity revealed by global expression profiling
, 2003
Endothelial dysfunction: Clinical strategies for treating oxidant stress
, 2003
The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema
, 2003
Immune traffic: a functiol overview.
, 2003
Animal models for the study of lymphatic insufficiency.
, 2003
Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy
, 2002
Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema - A r
, 2002
Therapeutic lymphangiogenesis with human recombint VEGF-C.
, 2002
Lymphedema-lymphangiectasia-mental retardation (Hennekam) syndrome: A review
, 2002
Myocarditis in systemic lupus erythematosus
, 2002
Therapeutic lymphangiogenesis with human recombint VEGF-C
, 2002
Diagnosis and treatment of concomitant venous obstruction in patients with secondary lymphedema
, 2002
Therapeutic lymphangiogenesis in a rabbit ear model of chronic post
, 2002
A model for chronic, post-surgical lymphatic insufficiency
, 2002
A model of acute, post-surgical lymphedema
, 2002
Preclinical models of lymphatic disease - The potential for growth factor and gene therapy
, 2002
The lymphatic continuum - The past, present, and exciting future of lymphatic research
, 2002
The role of chemokines in human cardiovascular pathology: enhanced biological insights
, 2002
Feasibility and reliability of rapid diagnosis of myocardial infarction
, 2001
Photoangioplasty recount: Clear punch or dimpled chad? Response
, 2001
Angiogenesis and the ischaemic heart
, 2001
Formulating clinical strategies for angiotensin antagonism
, 2001
Lymphedema
, 2001
Photoangioplasty for human peripheral atherosclerosis
, 2000
Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema
, 2000
Photoangioplasty - An emerging clinical cardiovascular role for photodymic therapy
, 2000
Benefits of lipid-lowering agents in stroke and corory heart disease: pharmacoeconomics.
, 2000
Lymphedema.
, 2000
Lymphoscintigraphic manifestations of Hennekam syndrome - A case report
, 1999
Fibroblast growth factor as therapy for critical limb ischemia: a case report
, 1999
Images in vascular medicine. Complex lower extremity edema in a young woman.
, 1999
Lutetium Texaphyrin: A New Therapeutic Tool for Human Atherosclerosis.
, 1999
Precipitating factors in lymphedema: Myths and realities
, 1998
American Cancer Society Lymphedema Workshop. Workgroup III: Diagnosis and magement of lymphedema.
Workgroup III - Diagnosis and magement of lymphedema
, 1998
Myocardial ischemia and infarction due to multiple corory-cameral fistulae
, 1998
Images in vascular medicine. Phlegmasia coerulea dolens--venous gangrene.
, 1998
Images in vascular medicine. Lymphoscintigraphy in congenital lymphedema.
, 1998
Lymphedema: classification, diagnosis and therapy.
, 1998
Peripheral arterial insufficiency: mechanisms, tural history, and therapeutic options.
, 1998
Lymphedema: atomy, physiology and pathogenesis.
, 1997
Limitations of Quantitative Corory Angiography
Lymphedema: A review of the relevant atomy and physiology of the lymphatics.
, 1997
A novel therapy for lymphedema complicated by lymphorrhea.
, 1996
Pregncy-associated group B streptococcal endocarditis: a report of two fatal cases.
, 1985
PREGNCY-ASSOCIATED GROUP-B STREPTOCOCCAL ENDOCARDITIS - A REPORT OF 2 FATAL CASES
, 1985
PURIFICATION AND CHARACTERIZATION OF THE MAMMALIAN BETA-2-ADRENERGIC RECEPTOR
, 1983
AN ANTIIDIOTYPIC ANTIBODY THAT RECOGNIZES THE BETA-ADRENERGIC-RECEPTOR
, 1982
CELLULAR MECHANISMS OF IMPAIRED ADRENERGIC RESPONSIVENESS IN NEOTAL DOGS
, 1981
ANTI-ALPRENOLOL ANTIBODIES IN THE RABBIT
, 1980
PLASMA DOPAMINE-BETA-HYDROXYLASE IN DIAGNOSIS OF NEUROBLASTOMA
, 1976
PLASMA DOPAMINE-BETA-HYDROXYLASE ACTIVITY IN ORAL-CONTRACEPTIVE HYPERTENSION
, 1975
LESCH-NYHAN SYNDROME - EVIDENCE FOR ABNORMAL ADRENERGIC FUNCTION
, 1974
SOLITARY REL CYST WITH SEGMENTAL ISCHEMIA AND HYPERTENSION
, 1974